Atul Pande
Director at IMVT; Director at Karuna Therapeutics, Inc.
Filed with the SEC as Pande Atul
- Sold, on record
- $8.7M
- Dollars the filings state
- Form 4 sales
- 28
- Latest Nov 11, 2026
- Form 144 notices
- 5
- Proposed sales
- Quarters with a sale
- 3 of the last 8
- 6 days with a sale in that time
- Companies
- 2
- Filed as an executive or holder
Companies
- IMVTImmunovant, Inc.Director
- Karuna Therapeutics, Inc.Director
Sales by reason
8
Routine
0
Plan not stated
0
No plan
20
Unusual
Form 4 sales per year, every sale on record.
Sales by company
- Karuna Therapeutics, Inc.73,214 shares
- IMVT35,100 shares
Shares sold, every Form 4 sale on record.
Timeline
- Nov 11, 2026Routine
Sold 2.5% of their holdings
$108k3,000 shares at $36.00
- Nov 11, 2026Notice
Filed a notice to sell 6,000 shares
$214k6,000 shares
- Aug 28, 2026Routine
Sold 1.3% of their holdings
$65k1,500 shares at $43.27
- Jul 24, 2026Routine
Sold 1.3% of their holdings
$60k1,500 shares at $39.80
- Jun 26, 2026Routine
Sold 1.3% of their holdings
$57k1,500 shares at $38.01
- Jun 15, 2026Routine
Sold 1.3% of their holdings
$51k1,500 shares at $34.02
- Jun 15, 2026Notice
Filed a notice to sell 6,000 shares
$202k6,000 shares
- May 20, 2026Routine
Sold 4.9% of their holdings
$192k6,000 shares at $32.00
- May 20, 2026Notice
Filed a notice to sell 6,000 shares
$158k6,000 shares
- Dec 2, 2024Routine
Sold 8.2% of their holdings
$221k7,750 shares at $28.54
10 of 33
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| Nov 11, 2026 | Nov 12, 2026 | IMVT | Director | Sold | 3,000 | $36.00 | $108k | 116,731 | SEC |
| Nov 11, 2026 | Nov 12, 2026 | IMVT | Director | Exercised or settledStock Option (right to buy) | 3,000 | 62,181 | SEC | ||
| Nov 11, 2026 | Nov 12, 2026 | IMVT | Director | Exercised options | 3,000 | $8.43 | $25k | 119,731 | SEC |
| Aug 28, 2026 | Aug 28, 2026 | IMVT | Director | Sold | 1,500 | $43.27 | $65k | 116,731 | SEC |
| Aug 28, 2026 | Aug 28, 2026 | IMVT | Director | Exercised or settledStock Option (right to buy) | 1,500 | 65,181 | SEC | ||
| Aug 28, 2026 | Aug 28, 2026 | IMVT | Director | Exercised options | 1,500 | $8.43 | $13k | 118,231 | SEC |
| Jul 24, 2026 | Jul 24, 2026 | IMVT | Director | Sold | 1,500 | $39.80 | $60k | 116,731 | SEC |
| Jul 24, 2026 | Jul 24, 2026 | IMVT | Director | Exercised or settledStock Option (right to buy) | 1,500 | 66,681 | SEC | ||
| Jul 24, 2026 | Jul 24, 2026 | IMVT | Director | Exercised options | 1,500 | $8.43 | $13k | 118,231 | SEC |
| Jun 26, 2026 | Jun 26, 2026 | IMVT | Director | Sold | 1,500 | $38.01 | $57k | 116,731 | SEC |
| Jun 26, 2026 | Jun 26, 2026 | IMVT | Director | Exercised or settledStock Option (right to buy) | 1,500 | 68,181 | SEC | ||
| Jun 26, 2026 | Jun 26, 2026 | IMVT | Director | Exercised options | 1,500 | $8.43 | $13k | 118,231 | SEC |
| Jun 15, 2026 | Jun 16, 2026 | IMVT | Director | Sold | 1,500 | $34.02 | $51k | 116,731 | SEC |
| Jun 15, 2026 | Jun 16, 2026 | IMVT | Director | Exercised or settledStock Option (right to buy) | 1,500 | 69,681 | SEC | ||
| Jun 15, 2026 | Jun 16, 2026 | IMVT | Director | Exercised options | 1,500 | $8.43 | $13k | 118,231 | SEC |
| May 20, 2026 | May 20, 2026 | IMVT | Director | Sold | 6,000 | $32.00 | $192k | 116,731 | SEC |
| May 20, 2026 | May 20, 2026 | IMVT | Director | Exercised or settledStock Option (right to buy) | 6,000 | 270,252 | SEC | ||
| May 20, 2026 | May 20, 2026 | IMVT | Director | Exercised options | 6,000 | $8.43 | $51k | 122,731 | SEC |
| Apr 7, 2026 | Apr 9, 2026 | IMVT | Director | AwardedStock Option (right to buy) | 7,061 | 7,061 | SEC | ||
| Apr 7, 2026 | Apr 9, 2026 | IMVT | Director | Awarded | 13,880 | 116,731 | SEC | ||
| Apr 1, 2025 | Apr 3, 2025 | IMVT | Director | AwardedStock Option (right to buy) | 7,600 | 7,600 | SEC | ||
| Apr 1, 2025 | Apr 3, 2025 | IMVT | Director | Awarded | 16,188 | 102,851 | SEC | ||
| Dec 2, 2024 | Dec 4, 2024 | IMVT | Director | Sold | 7,750 | $28.54 | $221k | 86,663 | SEC |
| Apr 2, 2024 | Apr 4, 2024 | IMVT | Director | AwardedStock Option (right to buy) | 4,690 | 4,690 | SEC | ||
| Apr 2, 2024 | Apr 4, 2024 | IMVT | Director | Awarded | 11,255 | 94,413 | SEC | ||
| Mar 18, 2024 | Mar 18, 2024 | Karuna Therapeutics, Inc. | Director | Returned to the companyOption (right to buy) | 27,904 | $212.62 | $5.9M | 0 | SEC |
| Mar 18, 2024 | Mar 18, 2024 | Karuna Therapeutics, Inc. | Director | Returned to the company | 990 | $330.00 | $327k | 0 | SEC |
| Dec 1, 2023 | Dec 5, 2023 | IMVT | Director | Sold | 12,350 | $39.73 | $491k | 83,158 | SEC |
| Jun 20, 2023 | Jun 22, 2023 | Karuna Therapeutics, Inc. | Director | AwardedOption (right to buy) | 1,904 | 1,904 | SEC | ||
| Jun 20, 2023 | Jun 22, 2023 | Karuna Therapeutics, Inc. | Director | Awarded | 990 | 990 | SEC | ||
| Apr 12, 2023 | Apr 14, 2023 | IMVT | Director | AwardedStock Option (right to buy) | 16,260 | 16,260 | SEC | ||
| Apr 12, 2023 | Apr 14, 2023 | IMVT | Director | Awarded | 12,523 | 95,508 | SEC | ||
| Sep 30, 2022 | Oct 4, 2022 | IMVT | Director | Bought | 15,000 | $5.60 | $84k | 20,000 | SEC |
| Aug 17, 2022 | Aug 19, 2022 | IMVT | Director | AwardedStock Option (right to buy) | 31,668 | 31,668 | SEC | ||
| Aug 17, 2022 | Aug 19, 2022 | IMVT | Director | Awarded | 21,059 | 82,985 | SEC | ||
| Jun 15, 2022 | Jun 16, 2022 | Karuna Therapeutics, Inc. | Director | AwardedOption (right to buy) | 5,000 | 5,000 | SEC | ||
| Feb 1, 2022 | Feb 2, 2022 | Karuna Therapeutics, Inc. | Director | Sold | 2,500 | $110.80 | $277k | 0 | SEC |
| Feb 1, 2022 | Feb 2, 2022 | Karuna Therapeutics, Inc. | Director | Exercised or settledOption (right to buy) | 2,500 | 0 | SEC | ||
| Feb 1, 2022 | Feb 2, 2022 | Karuna Therapeutics, Inc. | Director | Exercised options | 2,500 | $16.00 | $40k | 2,500 | SEC |
| Jan 10, 2022 | Jan 12, 2022 | IMVT | Director | AwardedStock Option (right to buy) | 71,492 | 208,973 | SEC | ||
| Jan 10, 2022 | Jan 12, 2022 | IMVT | Director | Awarded | 21,726 | 61,926 | SEC | ||
| Jan 3, 2022 | Jan 3, 2022 | Karuna Therapeutics, Inc. | Director | Sold | 2,500 | $130.44 | $326k | 0 | SEC |
| Jan 3, 2022 | Jan 3, 2022 | Karuna Therapeutics, Inc. | Director | Exercised or settledOption (right to buy) | 2,500 | 2,500 | SEC | ||
| Jan 3, 2022 | Jan 3, 2022 | Karuna Therapeutics, Inc. | Director | Exercised options | 2,500 | $16.00 | $40k | 2,500 | SEC |
| Dec 1, 2021 | Dec 2, 2021 | Karuna Therapeutics, Inc. | Director | Sold | 2,500 | $127.73 | $319k | 0 | SEC |
| Dec 1, 2021 | Dec 2, 2021 | Karuna Therapeutics, Inc. | Director | Exercised or settledOption (right to buy) | 2,500 | 5,000 | SEC | ||
| Dec 1, 2021 | Dec 2, 2021 | Karuna Therapeutics, Inc. | Director | Exercised options | 2,500 | $16.00 | $40k | 2,500 | SEC |
| Nov 1, 2021 | Nov 3, 2021 | Karuna Therapeutics, Inc. | Director | Sold | 2,500 | $136.67 | $342k | 0 | SEC |
| Nov 1, 2021 | Nov 3, 2021 | Karuna Therapeutics, Inc. | Director | Exercised or settledOption (right to buy) | 2,500 | 7,500 | SEC | ||
| Nov 1, 2021 | Nov 3, 2021 | Karuna Therapeutics, Inc. | Director | Exercised options | 2,500 | $16.00 | $40k | 2,500 | SEC |
Page 1
Sales and notices (33)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Nov 11, 2026 | Nov 12, 2026 | IMVT | Director | Form 4 sale | 3,000 | $108k | 2.5% | Routine | SEC |
| Nov 11, 2026 | Nov 12, 2026 | IMVT | Director | Form 144 notice | 6,000 | $214k | Notice | SEC | |
| Aug 28, 2026 | Aug 28, 2026 | IMVT | Director | Form 4 sale | 1,500 | $65k | 1.3% | Routine | SEC |
| Jul 24, 2026 | Jul 24, 2026 | IMVT | Director | Form 4 sale | 1,500 | $60k | 1.3% | Routine | SEC |
| Jun 26, 2026 | Jun 26, 2026 | IMVT | Director | Form 4 sale | 1,500 | $57k | 1.3% | Routine | SEC |
| Jun 15, 2026 | Jun 16, 2026 | IMVT | Director | Form 4 sale | 1,500 | $51k | 1.3% | Routine | SEC |
| Jun 15, 2026 | Jun 15, 2026 | IMVT | Director | Form 144 notice | 6,000 | $202k | Notice | SEC | |
| May 20, 2026 | May 20, 2026 | IMVT | Director | Form 4 sale | 6,000 | $192k | 4.9% | Routine | SEC |
| May 20, 2026 | May 20, 2026 | IMVT | Director | Form 144 notice | 6,000 | $158k | Notice | SEC | |
| Dec 2, 2024 | Dec 4, 2024 | IMVT | Director | Form 4 sale | 7,750 | $221k | 8.2% | Routine | SEC |
| Dec 2, 2024 | Dec 2, 2024 | IMVT | Director | Form 144 notice | 7,750 | $219k | Notice | SEC | |
| Dec 1, 2023 | Dec 5, 2023 | IMVT | Director | Form 4 sale | 12,350 | $491k | 12.9% | Routine | SEC |
| Dec 1, 2023 | Dec 1, 2023 | IMVT | Director | Form 144 notice | 12,350 | $483k | Notice | SEC | |
| Feb 1, 2022 | Feb 2, 2022 | Karuna Therapeutics, Inc. | Director | Form 4 sale | 2,500 | $277k | 100.0% | Unusual | SEC |
| Jan 3, 2022 | Jan 3, 2022 | Karuna Therapeutics, Inc. | Director | Form 4 sale | 2,500 | $326k | 100.0% | Unusual | SEC |
| Dec 1, 2021 | Dec 2, 2021 | Karuna Therapeutics, Inc. | Director | Form 4 sale | 2,500 | $319k | 100.0% | Unusual | SEC |
| Nov 1, 2021 | Nov 3, 2021 | Karuna Therapeutics, Inc. | Director | Form 4 sale | 2,500 | $342k | 100.0% | Unusual | SEC |
| Oct 1, 2021 | Oct 1, 2021 | Karuna Therapeutics, Inc. | Director | Form 4 sale | 2,500 | $302k | 100.0% | Unusual | SEC |
| Sep 1, 2021 | Sep 1, 2021 | Karuna Therapeutics, Inc. | Director | Form 4 sale | 2,500 | $295k | 100.0% | Unusual | SEC |
| Aug 2, 2021 | Aug 2, 2021 | Karuna Therapeutics, Inc. | Director | Form 4 sale | 2,500 | $285k | 100.0% | Unusual | SEC |
| Jul 1, 2021 | Jul 1, 2021 | Karuna Therapeutics, Inc. | Director | Form 4 sale | 2,500 | $282k | 100.0% | Unusual | SEC |
| Jun 1, 2021 | Jun 1, 2021 | Karuna Therapeutics, Inc. | Director | Form 4 sale | 2,500 | $279k | 100.0% | Unusual | SEC |
| May 3, 2021 | May 3, 2021 | Karuna Therapeutics, Inc. | Director | Form 4 sale | 5,000 | $577k | 100.0% | Unusual | SEC |
| Mar 1, 2021 | Mar 3, 2021 | Karuna Therapeutics, Inc. | Director | Form 4 sale | 2,500 | $314k | 100.0% | Unusual | SEC |
| Feb 1, 2021 | Feb 1, 2021 | Karuna Therapeutics, Inc. | Director | Form 4 sale | 2,500 | $250k | 100.0% | Unusual | SEC |
| Dec 14, 2020 | Dec 14, 2020 | Karuna Therapeutics, Inc. | Director | Form 4 sale | 5,714 | $529k | 100.0% | Unusual | SEC |
| Nov 12, 2020 | Nov 12, 2020 | Karuna Therapeutics, Inc. | Director | Form 4 sale | 5,000 | $484k | 100.0% | Unusual | SEC |
| Nov 3, 2020 | Nov 3, 2020 | Karuna Therapeutics, Inc. | Director | Form 4 sale | 5,000 | $425k | 100.0% | Unusual | SEC |
| Sep 16, 2020 | Sep 18, 2020 | Karuna Therapeutics, Inc. | Director | Form 4 sale | 5,000 | $425k | 100.0% | Unusual | SEC |
| Aug 12, 2020 | Aug 14, 2020 | Karuna Therapeutics, Inc. | Director | Form 4 sale | 5,000 | $425k | 100.0% | Unusual | SEC |
| Aug 12, 2020 | Aug 14, 2020 | Karuna Therapeutics, Inc. | Director | Form 4 sale | 5,000 | $425k | 100.0% | Unusual | SEC |
| Jul 13, 2020 | Jul 13, 2020 | Karuna Therapeutics, Inc. | Director | Form 4 sale | 5,000 | $477k | 100.0% | Unusual | SEC |
| Jun 12, 2020 | Jun 15, 2020 | Karuna Therapeutics, Inc. | Director | Form 4 sale | 5,000 | $466k | 100.0% | Unusual | SEC |